Organizing pneumonia - Own experiences with clarthromycin treatment;Organizuja̧ce siȩ zapalenie płuc - Leczenie klarytromycyna̧

Pneumonologia i Alergologia Polska

Volumn 72, Issue 11-12, 2004, Pages 493-498

  Radzikowska, Elzbieta ^a   Wiatr, Elzbieta ^a   Langfort, Renata ^b   Bestry, Iwona ^c   Rudziński, Piotr ^b   Roszkowski, Kazimierz ^a  

^a Immun Inst Gruzlicy i Chorob Pluc   (Poland)

^b NONE   (Poland)

^c Klinika Chirurgii   (Poland)

Author keywords

Clarithromcin; Organizing pneumonia

Indexed keywords

CLARITHROMYCIN; PREDNISOLONE; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; DYSPNEA; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTHYROIDISM; OPEN LUNG BIOPSY; ORGANIZING PNEUMONIA; SMOKING; THORAX PAIN; TRANSBRONCHIAL BIOPSY; WEIGHT REDUCTION; MIDDLE AGED; PNEUMONIA; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; FEMALE; HUMANS; MIDDLE AGED; PNEUMONIA; TREATMENT OUTCOME;

EID: 23044500287     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Arakawa H, Kurihara Y, Niimi H i wsp. Bronchiolitis obliterans with organizinig pneumonia versus chronic eosynophilic pneumonia: high-resolution CT findings in 81 patients. Am J Roentgenol 2001;176:1053-8
2. Arbetter KR, Parkash UB, Tazelaar HD, Douglas WW. Radiation- induced pneumonitis in the "nonirradiated" lung. Mayo Clin Proc 1999;74:27-36
3. Bellomo R, Finlay M, McLaughin P i wsp. Clinical spectrum of cryptogenic organising pneumonia. Thorax 1991;46: 554-8
4. Carre C, King T E, Mortensen R, Riches DWH. Cryptogenic organising pneumonia:increased expression of interleukin 8 and fibronectin genes by alveolar macrophages. Am Rev Respir Cell Mol Biol 1994;10:100-105
5. Cazzato S, Zompatori M, Baruzzi G i wsp. Bronchiolitis obliterans- organizing pneumonia: an Italian experience. Respir Med 2000;94:702-708
6. Cordier JF: Organising pneumonia. Thorax 2000;55: 318-28
7. Costabel U, Teshler H, Schoenfeld B i wsp. BOOP in Europe. Chest 1992;102:14-20s
8. Crestani B, Valeyre D, Roden S i wsp. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaries (GERM"O"P). Am J Respir Dis 1998;158:1929-35
9. Dorca J, Padrones S, Manresa F. Macrolides and lower respiratory tract infections. Eur Respir Mon 2004;28:78-93
10. Epler GR. Heterogeneity of bronchiolitis obliterans organizing pneumonia. Current Opin Pulm Med 1998;4:93-97
11. Gerhardt SG, McDyer JF, Girgis RE i wsp. Maintence of azithromycin therapy for bronchiolitis obliterans syndrome. Results of pilot study. Am J Respir Crit Care Med 2003;168: 121-125
12. Goncharova EA, Goncharov DA, Eszterhas A i wsp. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002;277:30958-67
13. Ianaro A, Ialenti A, Maffa P i wsp. Antiinflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000;292:156-163
14. Ichikawa Y, Ninomiya H, Katusuki M i wsp. Long-dose/long-term erythromycin for treatment of bronchiolitis obliterans organizing pneumonia (BOOP). Kurume Med J 1993;40:65-7
15. Ichimiya T, Takeoka K, Hiramatsu K i wsp. The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. Chemotherapy 1996;42:186-191
16. Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992;102:715-19
17. King TE Jr, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102: 8-13s
18. King TE Jr.: BOOP: an important cause of migratory pulmonary infiltrates? Eur Respir J 1995;8:193-5
19. Kudoh S. Erythromycin treatment in diffuse panbronchiolitis. Curr Opin Pulm Med 1998;4:116-121
20. Lohr RH, Boland BJ, Douglas WW i wsp.: Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Int Med 1997;157:1323-9
21. Poletti V, Cazzato S, Minicuci N i wsp.: The diagnostic value of bronchoalveolar lavage and transbronchial biopsy in cryptogenic organizing pneumonia. Eur.Respir.J. 1996;9:2513
22. Radzikowska E, Wiatr E, Remiszewski P i wsp. Organizujace siȩ zapalenie płuc - analiza 18 przypadków. Pneumonol Alerg Pol 2004; 72, 94-104.
23. Radzikowska E, Szczepulska E., Chabowski M., Bestry I. Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer. Eur Respir J 2003;21:552-5
24. Remiszewski P, Słodkowska J, Pawlicka L i wsp. Bronchiolitis obliterans organizing pneumonia - doświadczenia własne. Pol Merk Lek 1998;5:372-376
25. Colombo A., Orlic D., Stankovic G i wsp. Preliminary observations regarding angiografic pattern of restenosis after rapamycin eluting stent implantation. Circulation 2003; 107: 2178-80.
26. Watanabe K, Senju S, Wen F-O et al. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest 1998;114:1599-1606
27. Watanabe K, Senju S, Maeda F, Yshida M. Four cases of bronchiolitis obliterans organizing pneumonia associated thyroid disease. Respiration 2000;67:572-6
28. Wolter J, Seeney S, Bell S I wsp. Effect of long term treatment with azithriomycin on disease parameters in cystic fibrosis: a randomized trial. Thorax. 2002;57:212-6.